Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Jul;54(1):87-95.
doi: 10.1046/j.1365-2125.2002.01625.x.

Measurement of renal function during drug development

D Craig Brater  1
Affiliations
Review

Measurement of renal function during drug development

D Craig Brater. Br J Clin Pharmacol. 2002 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic of different drug administration methods for determining the renal clearance of a marker or drug. Panel a shows plasma drug concentration-time curves after a single i.v. (descending curve) and oral (ascending curve) dose. Panel b shows a linear plasma drug disappearance curve. Panel c shows a constant plasma drug concentration at steady state during continuous i.v. infusion (from reference 16, with permission).
Figure 2
Figure 2
Clearance of superoxide dismutase (SOD) as a function of dose. Note that total clearance remains relatively constant while renal clearance as a percent of total clearance increases with dose. This occurs because at higher doses proximal tubular metabolism of SOD is overwhelmed allowing recovery of unchanged SOD in the urine and a more accurate assessment of the contribution of renal clearance. Estimates of renal clearance with low doses are inaccurate because the SOD cleared by the kidney never reaches the urine owing to proximal metabolism.
Figure 3
Figure 3
Schematic of a ‘futile cycle’ of drug metabolism where acyl-glucuronide metabolites are retained in patients with renal insufficiency. They are then able to spontaneously hydrolyse back to parent drug in the circulation resulting in its accumulation even though the parent drug per se undergoes no direct renal excretion.
Figure 4
Figure 4
Effect of urinary pH on the elimination half-life of pseudoephedrine. Since pseudoephridine is a weak base, as urine pH becomes more alkaline, the concentration of nonionized drug in tubular fluid increases and is subject to reabsorption. This decreases renal elimination and prolongs the half-life (from reference 20 with permission).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zaltzman JS, Whiteside C, Cattran DC, Lopez FM, Logan AG. Accurate measurement of impaired glomerular filtration using single-dose oral cimetidine. Am J Kidney Dis. 1996;27:504–511. - PubMed
    1. Roubenoff R, Drew H, Moyer M, Petri M, Whiting-O'Keefe Q, Hellmann DB. Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis. Ann Intern Med. 1990;113:501–506. - PubMed
    1. Bianchi C, Donadio C, Tramonti G. Noninvasive methods for the measurement of total renal function. Nephron. 1981;28:53–57. - PubMed
    1. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int. 1990;38:167–184. - PubMed
    1. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–838. - PubMed